Internists, Cardiologist (heart)
10 years of experience

University Area
3841 Piper St
Ste T100
Anchorage, AK 99508
907-561-3211
Locations and availability (2)

Education ?

Medical School Score Rankings
Duke University (2000)
  • Currently 4 of 4 apples
Top 25%

Awards & Distinctions ?

Associations
American Board of Internal Medicine

Affiliations ?

Dr. Amos is affiliated with 8 hospitals.

Hospital Affilations

Score

Rankings

  • Valley Hospital
    Cardiology
    2500 S Woodworth Loop, Palmer, AK 99645
    • Currently 3 of 4 crosses
    Top 50%
  • Alaska Regional Hospital
    Cardiology
    2801 Debarr Rd, Anchorage, AK 99508
    • Currently 3 of 4 crosses
    Top 50%
  • Providence Alaska Medical Center
    Cardiology
    PO Box 196604, Anchorage, AK 99519
    • Currently 2 of 4 crosses
  • Durham VA Medical
  • Alaska Heart Institute, LLC
  • Duke University Hospital
  • Southeastern Regional Medical Center
  • Providence Extended Care Center
    4900 Eagle St, Anchorage, AK 99503
  • Publications & Research

    Dr. Amos has contributed to 5 publications.
    Title Improved Outcomes in Peripartum Cardiomyopathy with Contemporary.
    Date September 2006
    Journal American Heart Journal
    Excerpt

    BACKGROUND: Prior studies have shown both high morbidity and mortality for patients with peripartum cardiomyopathy (PPCM). These studies were small and predated current advances in heart failure treatment. We sought to determine the outcomes of women with PPCM in the contemporary era and to determine predictors of poor outcome. METHODS: Patients with PPCM from 1990 to 2003 were identified retrospectively through screening of heart failure clinics and echocardiography records. Their records were reviewed, and current clinical status was determined. RESULTS: Fifty-five patients were identified with an average follow-up of 43 months. Their mean initial ejection fraction (EF) was 20%. Compared with their initial EF, 62% of patients improved, 25% were unchanged, and 4% declined. No patients died, and 10% eventually required transplant. At 2 months after diagnosis, 75% of those who eventually recovered had an EF >45%. Factors associated with lack of recovery at initial assessment were a left ventricular (LV) end-diastolic dimension >5.6 cm, the presence of LV thrombus, and African-American race. Recovery of LV function was not predicted by the initial EF. Among patients who recovered, the withdrawal of heart failure medications was not associated with decompensation over a follow-up of 29 months. CONCLUSIONS: The morbidity related to PPCM is less than previously reported. Initial LV end-diastolic dimension and EF at 2 months predict long-term outcomes. The discontinuation of heart failure medications after recovery did not lead to decompensation.

    Title Bilateral Ureteritis Cystica with Unilateral Ureteropelvic Junction Obstruction.
    Date September 1999
    Journal Techniques in Urology
    Excerpt

    Ureteritis cystica is a rare, benign, proliferative disorder characterized by multiple ureteral cysts and multiple filling defects noted on contrast ureteral imaging. A unique case of bilateral ureteritis cystica coincidental with chronic, congenital, unilateral ureteropelvic junction obstruction presenting with microscopic hematuria and lower urinary tract symptoms is described. The characteristic presentation as well as the diagnostic radiographic, ureteroscopic, and histologic features of pyeloureteritis cystica are reviewed.

    Title Cushing's Syndrome Associated with a Pheochromocytoma.
    Date August 1998
    Journal Urology
    Excerpt

    A norepinephrine producing right adrenal pheochromocytoma was associated with bilateral adrenal hyperplasia and clinically and biochemically evident Cushing's syndrome. Ectopic adrenocorticotropin production was suspected, but the six criteria for proof of ectopic adrenocorticotropin production could not be demonstrated. The diagnosis of Cushing's syndrome from ectopic hormone production by a pheochromocytoma requires a high index of suspicion and extensive biochemical and radiographic testing to confirm Cushing's syndrome, identify the cause of Cushing's syndrome, and localize the pheochromocytoma.

    Title The Utility of Video-assisted Thoracic Surgery in the Diagnosis of Pulmonary Metastases from Renal Cell Carcinoma.
    Date February 1997
    Journal Urology
    Excerpt

    The definitive diagnosis of pulmonary metastases requires histologic confirmation. Traditional methods of obtaining tissue for histologic review include transbronchial approaches, percutaneous transthoracic needle biopsy, and open lung biopsy. The purpose of this study is to identify the most effective methods of obtaining histologic confirmation of pulmonary metastases. The utility of video-assisted thoracic surgery in diagnosing pulmonary metastases is demonstrated in 2 patients with metastatic renal cell carcinoma. The diagnostic yields and complication rates of transbronchial approaches, percutaneous needle biopsy, open lung biopsy, and video-assisted thoracic surgery are compared. Finally, an algorithm for the evaluation of pulmonary lesions is presented.

    Title Results of Lower Extremity Amputations in Patients with End-stage Renal Disease.
    Date August 1994
    Journal Journal of Vascular Surgery : Official Publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter
    Excerpt

    PURPOSE: The purpose of this study was to determine the impact of end-stage renal disease (ESRD) on the outcome of patients undergoing lower extremity (LE) amputation. METHODS: Hospital charts and vascular surgery registry data were reviewed for all patients who underwent LE amputation over a consecutive 56-month period. The results of 84 patients with ESRD (137 amputations) were compared with 375 patients (442 amputations) without ESRD. RESULTS: Hospital mortality rate was significantly greater in patients with ESRD than patients without ESRD, 24% versus 7% (p = 0.001). Patients with ESRD undergoing minor amputations had mortality rates three times greater than patients without ESRD undergoing major LE amputations. In patients with ESRD requiring bilateral or unilateral above-knee amputation hospital mortality rates were 43% and 38%, respectively. In addition, patients with ESRD were seven times more likely to undergo bilateral amputation than patients without ESRD over a mean follow-up period of 17 months. No kidney transplant patients died after amputation. CONCLUSION: ESRD has a profound negative impact on morbidity, mortality, and survival rates after LE amputation. Attempts at prevention of amputation with aggressive foot care and patient education in this high-risk group should be the focus of therapy.


    Similar doctors nearby

    Dr. Paul Peterson

    Internal Medicine
    25 years experience
    Anchorage, AK

    Dr. William Kutchera

    Internal Medicine
    22 years experience
    Anchorage, AK

    Dr. David Sonneborn

    Internal Medicine
    36 years experience
    Anchorage, AK

    Dr. Stanley Watkins

    Internal Medicine
    13 years experience
    Anchorage, AK

    Dr. Eric Meier

    Allergy & Immunology
    13 years experience
    Anchorage, AK

    Dr. Thomas Kramer

    Internal Medicine
    30 years experience
    Anchorage, AK
    Search All Similar Doctors